These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28610415)

  • 1. Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells.
    Javan Maasomi Z; Pilehvar Soltanahmadi Y; Dadashpour M; Alipour Sh; Abolhasani S; Zarghami N
    Asian Pac J Cancer Prev; 2017 May; 18(5):1283-1287. PubMed ID: 28610415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Anti-proliferative Effects of Metformin and Silibinin Combination on T47D Breast Cancer Cells via hTERT and Cyclin D1 Inhibition.
    Chatran M; Pilehvar-Soltanahmadi Y; Dadashpour M; Faramarzi L; Rasouli S; Jafari-Gharabaghlou D; Asbaghi N; Zarghami N
    Drug Res (Stuttg); 2018 Dec; 68(12):710-716. PubMed ID: 29920623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression.
    Rasouli S; Zarghami N
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):977-982. PubMed ID: 29693804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of PEGylated PLGA Nanoparticles Co-Loaded with Bioactive Compounds: Potential Anticancer Effect on Breast Cancer Cell Lines.
    Mohammadinejad S; Jafari-Gharabaghlou D; Zarghami N
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4063-4072. PubMed ID: 36579986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells.
    Jafari-Gharabaghlou D; Pilehvar-Soltanahmadi Y; Dadashpour M; Mota A; Vafajouy-Jamshidi S; Faramarzi L; Rasouli S; Zarghami N
    Iran J Basic Med Sci; 2018 Nov; 21(11):1167-1173. PubMed ID: 30483391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Development of Nanostructured Co Delivery of Artemisinin and Chrysin for Targeting hTERT Gene Expression in Breast Cancer Cell Line: Possible Clinical Application in Cancer Treatment.
    Khoshravan L; Dadashpour M; Hashemi M; Zarghami N
    Asian Pac J Cancer Prev; 2022 Mar; 23(3):919-927. PubMed ID: 35345364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of Silibinin Effects on Cell Cycling and Apoptosis in Human Breast Cancer MCF-7 and T47D Cell Lines.
    Jahanafrooz Z; Motameh N; Bakhshandeh B
    Asian Pac J Cancer Prev; 2016; 17(5):2661-5. PubMed ID: 27268647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hTERT Gene Expression by Silibinin-Loaded PLGA-PEG-Fe3O4 in T47D Breast Cancer Cell Line.
    Ebrahimnezhad Z; Zarghami N; Keyhani M; Amirsaadat S; Akbarzadeh A; Rahmati M; Mohammad Taheri Z; Nejati-Koshki K
    Bioimpacts; 2013; 3(2):67-74. PubMed ID: 23878789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.
    Gu HR; Park SC; Choi SJ; Lee JC; Kim YC; Han CJ; Kim J; Yang KY; Kim YJ; Noh GY; No SH; Jeong JH
    Clin Mol Hepatol; 2015 Mar; 21(1):49-59. PubMed ID: 25834802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells.
    Motawi TM; Sadik NA; Fahim SA; Shouman SA
    Chem Biol Interact; 2015 May; 233():147-56. PubMed ID: 25863232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
    Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
    Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells.
    Kim S; Lee HS; Lee SK; Kim SH; Hur SM; Kim JS; Kim JH; Choe JH; Shin I; Yang JH; Lee JE; Nam SJ
    Phytomedicine; 2010 Dec; 17(14):1127-32. PubMed ID: 20554189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Therapy with Silibinin Improves the Efficacy of Paclitaxel and Cisplatin in MCF-7 Breast Cancer Cells.
    Chavoshi H; Vahedian V; Saghaei S; Pirouzpanah MB; Raeisi M; Samadi N
    Asian Pac J Cancer Prev; 2017 Aug; 18(8):2243-2247. PubMed ID: 28843263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chrysin, Abundant in Morinda citrifolia Fruit Water-EtOAc Extracts, Combined with Apigenin Synergistically Induced Apoptosis and Inhibited Migration in Human Breast and Liver Cancer Cells.
    Huang C; Wei YX; Shen MC; Tu YH; Wang CC; Huang HC
    J Agric Food Chem; 2016 Jun; 64(21):4235-45. PubMed ID: 27137679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
    Hogan FS; Krishnegowda NK; Mikhailova M; Kahlenberg MS
    J Surg Res; 2007 Nov; 143(1):58-65. PubMed ID: 17950073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines.
    Jahanafrooz Z; Motamed N; Bakhshandeh B
    Cytotechnology; 2017 Aug; 69(4):667-680. PubMed ID: 28321778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
    Bhatia N; Agarwal C; Agarwal R
    Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
    Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.